BB reagents

0.0(0)
studied byStudied by 0 people
0.0(0)
call with kaiCall with Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/9

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No study sessions yet.

10 Terms

1
New cards

Reagent regulations

  • how is blood regulated

  • what certifies reagents

  • regulation criterias

Blood regulated like drug by FDA

  • CBER certifies reagents → establish minimum criteria

    • Package insert (instructions)

      • Intention + how it is made + testing info

    • Facility policies

    • Reagent QC done on day of use

2
New cards

Polyclonal vs monoclonal Abs vs blended

  • Polyclonal: mixture of IgM and IgG Abs made by B cell clones to detect multiple epitopes on Ag

  • Monoclonal: hybridomas derived from myeloma cells to target specific epitope w/ IgM OR IgG

  • Blended: diversity (either monoclonal or poly + mono)

    • overcomes disadvantages of over specificity of monoclonal

3
New cards

ABO antigen typing

  • forward grouping

  • use of monoclonal IgM

D antigen typing

  • high vs low protein

Reagent control

  • when to use

ABO antigen typing

  • forward grouping: looking for Ag

    • determine ABO phenotype of pt cells (use anti-A and anti-B + agglutination)

  • monoclonal IgM helps detect weak A and B Ag expression

D antigen typing

  • High protein = historical- not used anymore

  • Low protein = monoclonal or mono/poly blends

    • IgM Abs = immediate spin

    • IgG Abs = weak D testing

Reagent control

  • high-protein reagents

  • A, B, and D testing all positive

4
New cards

Reagent RBCs

  • what is it?

  • types and use

  • Known Ag for detecting unknown Ab

  • A1 and B cells:

    • used for reverse grouping: looking for Ab → confirms forward testing

  • Screening cells:

    • detects non-ABO Abs

  • Panel cells

    • wider range of cells to specify Ab detected

5
New cards

Antihuman globulin

  • purpose

  • examples

  • DAT vs IAT

  • AHG control cells types

  • bridges gap bc IgG too tiny for agglutination

  • anti-IgG, anti-C3d, polyspecific AHG (both), monospecific AHG (seperate)

  • DAT: in vivo; 1 step (cells alr sensitized)

  • IAT: in vitro; 2 steps (incubate for sensitization)

  • AHG control cells:

    • IgG coated or C3 coated group O cells

    • confirm neg rxns

6
New cards

Potentiators

  • what is it

  • what does it do

  • what types + what they do + effect

  • “Enhancement media”

  • looks for IgG in IAT

  • low-ionic strength solution (LISS)

    • reduces electrostatic charge around RBC = better Ab uptake + agglutination

  • Polyethylene glycol (PEG)

    • removes water molecules → RBC get closer + concentrates Ab enhancing uptake

  • Bodine albumin

    • allow Ab sensitized cells to come together = better agglutination

7
New cards

Enzymes

  • proteolytic?

  • destroys what

  • enhances what

  • common enzymes

  • Proteolytic: removes neg charges and glycoprotein fragments from RBC

  • Destroyed by enzymes: duffy, MNS

  • “Enhanced” by enzymes: ABO, Rh, Lewis, Kidd, H, I, Lutheran

  • Common enzymes:

    • Ficin- from figs

    • Papain- from papauas

    • Bromelain- from pineapples

8
New cards

Lectins

  • what?

  • types?

  • Alternate to antisera → cause agglutination 

  • Types

    • Dolicho biflorus: anti-A1 lectin 

    • Ulex europaeus: anti-H lectin

9
New cards

Sources of errors in agglutination

  • false pos

  • false neg

False positive 

False negative

Dirty glassware

Delayed testing → not adding AHG immediately

agglutinated RBC present before washing then added AGH

Failed to wash before adding AHG

Over centrifugation 

Failed to ID weak pos rxn

No adding AHG

Loss of reagent activity

Under centrifugation

Inappropriate RBC concentration → RBC suspension fall outside optimal 2-5%

10
New cards

Are the following IAT or DAT?

  1. Drug-related mechanisms (IgG–drug complex on RBC)

  2. Antibody screening (detect atypical non-ABO antibodies before transfusion)

  3. IgG and/or C3 bound to patient RBCs

  4. Abs produced by passenger lymphocytes (donor B cells attack recipient RBCs)

  5. Weak D test (detects presence of D antigen)

  6. Passively acquired alloantibodies (transfused or infused antibodies)

  7. Nonspecifically absorbed proteins (globulins coating RBCs)

  8. Crossmatch (tests serologic compatibility)

  9. Donor or fetal cells sensitized with IgG antibodies

  10. Antigen typing

  11. Activation of complement (C3 binds RBCs and is detected by AHG reagent)

  12. Antibody identification (determines antibody specificity in patient or donor)

  1. DAT

  2. IAT

  3. DAT

  4. DAT

  5. IAT

  6. DAT

  7. DAT

  8. IAT

  9. DAT

  10. IAT

  11. DAT

  12. IAT